Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Tox

Particle size (PS) and polydispersity index (PDI) for the lyophilized GLZ-loaded SLNs (10 F2) after reconstitution.PNG

Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study

6. March 2020

Introduction: Solid lipid nanoparticles (SLNs) are considered a promising system in enhancing the oral bioavailability of poorly water-soluble drugs; owing to...

Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery

21. August 2017

21. August 2017 Solid lipid nanoparticles (SLN) containing rifabutin (RFB), with pulmonary administration purposes, were developed through a technique that...

Microencapsulated SLN: An innovative strategy for pulmonary protein delivery

20. November 2016

Abstract Associating protein with nanoparticles is an interesting strategy to improve their bioavailability and biological activity. Solid lipid nanoparticles (SLN)...

The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN)

6. November 2016

Abstract Solid lipid microparticles (SLM) were produced by produced by a two-step process that, firstly, involved the emulsification of...

Development and characterization of the voriconazole loaded lipid-based nanoparticles

8. October 2016

08. October 2016 Abstract The number of topical fungal infections is growing, mostly owing to immunosuppressive therapy. Several topical fungal...

Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs

21. October 2015

21. October 2015 Nowadays exploration of novel lipid-based formulations is akin to a magnet for researchers worldwide for improving the...

Lipid Nanoparticles

Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study

Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery

Microencapsulated SLN: An innovative strategy for pulmonary protein delivery

The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN)

Development and characterization of the voriconazole loaded lipid-based nanoparticles

Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs

Cart

Shop Search

Top Pharma-Excipient Links

Welcome Back!

Retrieve your password